Ari Hasan, Ari Selma, Coşar Selvi, Celiloğlu Nuran, Aktaş İbrahim, Camci Sencer, Doğanay Kübra, Tütüncü Ahmet, Melek Mehmet
Bursa Postgraduate Hospital, Depar tment of Cardiology, Bursa, Turkey.
Cardiol J. 2015;22(5):551-6. doi: 10.5603/CJ.a2015.0038. Epub 2015 Jun 23.
Varenicline could affect the T wave and QT interval. The interval from the peak to the end of the electrocardiographic (ECG) T wave (Tp-e) may correspond to the transmural dispersion of repolarization, and increased Tp-e interval and Tp-e/QT ratio are associated with malignant ventricular arrhythmias. In this study, we assessed the effects of varenicline on Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio.
Thirty healthy volunteers (15 healthy non-smokers [NS] and 15 healthy smokers [S]) were included in the randomized, double-blind, placebo-controlled, crossover study. Varenicline (2 mg single dose) or placebo was administered in two different testing sessions (5 days after the first period, performed the second period). Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio were assessed in the supine position and during handgrip exercise before and after the participants were given placebo or varenicline. Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio were calculated from continuous ECG recordings and averages were used in the final analysis.
There were no statistically significant differences among any of the Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio before and after placebo administration in both groups (S and NS). In the S group, Tp-e and QTc interval, and Tp-e/QT and Tp-e/QTc ratio were significantly increased after varenicline administration (Tp-e: 64.28 ± 8.78 vs. 70.42 ± ± 13.12; p = 0.02, QTc: 409.57 ± 28.17 vs. 425.28 ± 32.79; p = 0.02, Tp-e/QT: 0.18 ± 0.02 vs. 0.19 ± 0.03; p = 0.04, Tp-e/QTc: 0.17 ± 0.02 vs. 0.19 ± 0.02; p = 001) but these parameters were not changed in the NS group.
Tp-e and QTc interval, and Tpe/QT and Tpe/QTc ratio were increased after varenicline administration in smokers.
伐尼克兰可能影响T波和QT间期。心电图(ECG)T波从峰值到结束的间期(Tp-e)可能对应复极的跨壁离散度,Tp-e间期和Tp-e/QT比值增加与恶性室性心律失常相关。在本研究中,我们评估了伐尼克兰对Tp-e间期、Tp-e/QT比值和Tp-e/QTc比值的影响。
30名健康志愿者(15名健康非吸烟者[NS]和15名健康吸烟者[S])被纳入随机、双盲、安慰剂对照、交叉研究。在两个不同的测试阶段给予伐尼克兰(单次剂量2 mg)或安慰剂(在第一阶段后5天进行第二阶段)。在给予安慰剂或伐尼克兰之前和之后,评估受试者仰卧位和握力运动时的Tp-e间期、Tp-e/QT比值和Tp-e/QTc比值。Tp-e间期、Tp-e/QT比值和Tp-e/QTc比值根据连续的心电图记录计算得出,最终分析采用平均值。
两组(S组和NS组)在给予安慰剂前后,Tp-e间期、Tp-e/QT比值和Tp-e/QTc比值中的任何一项均无统计学显著差异。在S组中,给予伐尼克兰后Tp-e和QTc间期以及Tp-e/QT和Tp-e/QTc比值显著增加(Tp-e:64.28±8.78对70.42±13.12;p = 0.02,QTc:409.57±28.17对425.28±32.79;p = 0.02,Tp-e/QT:0.18±0.02对0.19±0.03;p = 0.04,Tp-e/QTc:0.17±0.02对0.19±0.02;p = 0.01),但这些参数在NS组中未改变。
吸烟者服用伐尼克兰后Tp-e和QTc间期以及Tpe/QT和Tpe/QTc比值增加。